Literature DB >> 11853818

Generation of allocation sequences in randomised trials: chance, not choice.

Kenneth F Schulz1, David A Grimes.   

Abstract

The randomised controlled trial sets the gold standard of clinical research. However, randomisation persists as perhaps the least-understood aspect of a trial. Moreover, anything short of proper randomisation courts selection and confounding biases. Researchers should spurn all systematic, non-random methods of allocation. Trial participants should be assigned to comparison groups based on a random process. Simple (unrestricted) randomisation, analogous to repeated fair coin-tossing, is the most basic of sequence generation approaches. Furthermore, no other approach, irrespective of its complexity and sophistication, surpasses simple randomisation for prevention of bias. Investigators should, therefore, use this method more often than they do, and readers should expect and accept disparities in group sizes. Several other complicated restricted randomisation procedures limit the likelihood of undesirable sample size imbalances in the intervention groups. The most frequently used restricted sequence generation procedure is blocked randomisation. If this method is used, investigators should randomly vary the block sizes and use larger block sizes, particularly in an unblinded trial. Other restricted procedures, such as urn randomisation, combine beneficial attributes of simple and restricted randomisation by preserving most of the unpredictability while achieving some balance. The effectiveness of stratified randomisation depends on use of a restricted randomisation approach to balance the allocation sequences for each stratum. Generation of a proper randomisation sequence takes little time and effort but affords big rewards in scientific accuracy and credibility. Investigators should devote appropriate resources to the generation of properly randomised trials and reporting their methods clearly.

Entities:  

Mesh:

Year:  2002        PMID: 11853818     DOI: 10.1016/S0140-6736(02)07683-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  157 in total

Review 1.  Triphasic versus monophasic oral contraceptives for contraception.

Authors:  Huib A A M Van Vliet; David A Grimes; Laureen M Lopez; Kenneth F Schulz; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Letters to the Editor.

Authors:  Kristinn I. Heinrichs
Journal:  J Athl Train       Date:  2003-09       Impact factor: 2.860

3.  Pulse wave analysis in a pilot randomised controlled trial of auto-adjusting and continuous positive airway pressure for obstructive sleep apnoea.

Authors:  Jessie P Bakker; Angela J Campbell; Alister M Neill
Journal:  Sleep Breath       Date:  2010-07-14       Impact factor: 2.816

4.  Practical tips for surgical research. Ensuring balanced groups in surgical trials.

Authors:  Forough Farrokhyar; Sohail Bajammal; Kamyar Kahnamoui; Mohit Bhandari
Journal:  Can J Surg       Date:  2010-12       Impact factor: 2.089

5.  Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.

Authors:  Aikaterini J Megalou; Chryssoula Glava; Dimitrios L Oikonomidis; Agapi Vilaeti; Maria G Agelaki; Giannis G Baltogiannis; Apostolos Papalois; Antonios P Vlahos; Theofilos M Kolettis
Journal:  Int J Clin Exp Med       Date:  2010-10-23

6.  Is acupuncture no more than a placebo? Extensive discussion required about possible bias.

Authors:  Shizhe Deng; Xiaofeng Zhao; Rong DU; S I He; Yan Wen; Linghui Huang; Guang Tian; Chao Zhang; Zhihong Meng; Xuemin Shi
Journal:  Exp Ther Med       Date:  2015-07-23       Impact factor: 2.447

7.  Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis.

Authors:  R J McManus; J Mant; A Roalfe; R A Oakes; S Bryan; H M Pattison; F D R Hobbs
Journal:  BMJ       Date:  2005-08-22

Review 8.  Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review.

Authors:  Claudia Steurer-Stey; Leonie Lagler; Daniel A Straub; Johann Steurer; Lucas M Bachmann
Journal:  Eur J Pediatr       Date:  2006-11-18       Impact factor: 3.183

9.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

10.  INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY).

Authors:  William B White; Ravi Marfatia; Julia Schmidt; Dorothy B Wakefield; Richard F Kaplan; Richard W Bohannon; Charles B Hall; Charles R Guttmann; Nicola Moscufo; Douglas Fellows; Leslie Wolfson
Journal:  Am Heart J       Date:  2013-01-05       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.